The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-((2-(2-aminopyrimidin-5-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazine-1-carbonyl)benzofuran-7-carboxamide ID: ALA4871210
PubChem CID: 164619420
Max Phase: Preclinical
Molecular Formula: C29H29N9O4S
Molecular Weight: 599.68
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)c1cccc2cc(C(=O)N3CCN(Cc4cc5nc(-c6cnc(N)nc6)nc(N6CCOCC6)c5s4)CC3)oc12
Standard InChI: InChI=1S/C29H29N9O4S/c30-25(39)20-3-1-2-17-12-22(42-23(17)20)28(40)38-6-4-36(5-7-38)16-19-13-21-24(43-19)27(37-8-10-41-11-9-37)35-26(34-21)18-14-32-29(31)33-15-18/h1-3,12-15H,4-11,16H2,(H2,30,39)(H2,31,32,33)
Standard InChI Key: WARUZPFHLRLCHE-UHFFFAOYSA-N
Molfile:
RDKit 2D
43 49 0 0 0 0 0 0 0 0999 V2000
12.1739 -1.8779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1728 -2.6974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8808 -3.1064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8790 -1.4690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5876 -1.8743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5879 -2.6974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3709 -2.9516 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8546 -2.2855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3705 -1.6197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8810 -3.9235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1734 -4.3323 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.5888 -4.3319 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6718 -2.2852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0806 -2.9927 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0801 -1.5773 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6672 -3.7034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0726 -4.4088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8901 -4.4128 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3006 -3.7051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8936 -2.9934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2963 -5.1219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1135 -5.1247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5882 -5.7854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5928 -4.4633 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.3691 -4.7183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3648 -5.5390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0695 -5.9508 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7830 -5.5465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7873 -4.7258 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0781 -4.3094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4880 -5.9597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0812 -3.4922 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7969 -3.0878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8020 -2.2742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0977 -1.8591 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.3866 -2.2637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3798 -3.0835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4782 -6.7779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1823 -7.1911 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8937 -6.7872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8965 -5.9657 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.1918 -5.5563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5998 -7.2037 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
3 10 1 0
10 11 2 0
10 12 1 0
8 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
14 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
18 21 1 0
21 22 1 0
22 23 2 0
23 26 1 0
25 24 1 0
24 22 1 0
25 26 2 0
25 30 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
28 31 1 0
30 32 1 0
32 33 1 0
32 37 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
31 38 2 0
38 39 1 0
39 40 2 0
40 41 1 0
41 42 2 0
42 31 1 0
40 43 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 599.68Molecular Weight (Monoisotopic): 599.2063AlogP: 2.37#Rotatable Bonds: 6Polar Surface Area: 169.83Molecular Species: NEUTRALHBA: 12HBD: 2#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 6.05CX LogP: 1.96CX LogD: 1.94Aromatic Rings: 5Heavy Atoms: 43QED Weighted: 0.29Np Likeness Score: -1.53
References 1. Wu Z, Bai Y, Jin J, Jiang T, Shen H, Ju Q, Zhu Q, Xu Y.. (2021) Discovery of novel and potent PARP/PI3K dual inhibitors for the treatment of cancer., 217 [PMID:33740547 ] [10.1016/j.ejmech.2021.113357 ]